Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models - Concepedia

Concepedia

Publication | Open Access

Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models

DOI Full Paper Access

23

Citations

17

References

2013

Year

Sandip Pravin Patel, Andrew Bristol, Olga Saric, Xue-Ping Wang, Alex Dubeykovskiy, Philip M. Arlen, Michael A. Morse

Cancer Immunology Immunotherapy

Immunocytochemical TechniquePreclinical ModelsMedicineImmunologyImmunoeditingAntibody ScreeningImmune Checkpoint InhibitorAntibody EngineeringNovel Monoclonal AntibodyAnti-tumor ActivityImmunotherapyOncologyRadiation OncologyCancer ResearchTumor MicroenvironmentTumor BiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1